Новости GxP

gxpnews.net

#19 in Health among publishers in Google Discover in Latvia over the last 30 days.

Track in D2TR
LatviaLast 30 days
#19in Health
35DTRSDTRS, its score in Health
0.02%share of visibility
#19in Health

Reach per publication

182market average is 100A typical ⁨Новости GxP⁩ publication reaches more of Discover than the average one in this market.

Publication lifespan

1.8×the market averageIts publications stay in the feed longer than most before they drop out.
Feed positionAverage position in the feed and the number of publications are in D2TR.

Market share

Last 60 days
Share of visibilityImpressions per day1.7Kin the last 14 days
0.0%0.2%0.4%0.6%0.8%1.0%04008001.2K1.6K2KLast 14 daysSep 17Oct 2Oct 18Nov 2Nov 150.0%0.5%1.0%01K2KLast 14 daysSep 17Nov 2Impressions before Nov 2 are in D2TRUnlock the full historySign up to see daily impressions of ⁦gxpnews.net⁩ since May 2026 and every article behind them.Sign up

Slice of the market

0.02%of all Google Discover visibility in Latvia
  • Новости GxP0.02%
  • Rest of the top 1024.5%
  • Everyone else75.5%

Top publications

FDA взялось за расследование информации о риске развития опухолей после введения «Золгенсмы»

FDA launches investigation into reports of tumor risk after Zolgensma administration

Impressions985
HealthIn D2TR

В России разработали новый препарат от тромбов

New anti-clot drug developed in Russia

Impressions574
HealthIn D2TR

Пациенты указали на отсутствие в аптеках импортного препарата для лечения атопического дерматита

Patients report absence of imported drug Elidel for atopic dermatitis treatment in pharmacies

Impressions78
HealthIn D2TR

FDA в приоритетном порядке рассмотрит заявку uniQure на одобрение генной терапии болезни Хантингтона

FDA to prioritize review of uniQure's application for approval of Huntington's gene therapy

Impressions
HealthIn D2TR

Татьяна Голикова: онковакцину CaTeVac планируют применять с 2027 года

Tatiana Golikova: CaTeVac cancer vaccine planned for use from 2027

Impressions
HealthIn D2TR

Publications by impressions

ImpressionsPubsShare of total
Over 5M0%0%
1M to 5M0%0%
100K to 1M0%0%
10K to 100K0%0%
Under 10K100%100%

100% of its publications bring 100% of its impressions.

Where it ranks

By category

Impressions, last 14 days
Health1.7KUp 1 place against the previous period#19
Other categories0

What it publishes

Content formats

  • News100.0%

Top entities

Last 14 days
Food and Drug Administration1K

Top authors

Last 14 days
GxP News1.6K

About ⁨Новости GxP⁩

Main category
Health
In D2TR data
since May 2026

Google profile

Open profile
0total followers
Last 90 days

Its records

Best rank
outside the top 50 May
In the top 10
in no period on record
The numbers behind the rankSign up to open the full impressions history, feed positions, authors and every article of ⁦gxpnews.net⁩.
Sign up

Rank and share come from the D2TR publisher ranking and are rebuilt every 7 days. Impressions are shown for the last 14 days. Estimates, not Google data. D2TR is not affiliated with Google or with ⁨Новости GxP⁩.